ACE2 and infection: Moreover, the SARS-CoV-2 spike protein receptor-binding domain (RBD) and its receptor angiotensin converting enzyme 2 (ACE2) are proposed as critical therapeutic targets for SARS-CoV-2 entry and infection [6,7].